Jonathan D.J. Loeb Ph.D.

Jonathan D.J. Loeb, Ph.D.'s practice focuses on life sciences litigation and strategic patent counseling. To achieve his clients' strategic goals, Dr. Loeb melds the technical expertise gained in more than 10 years as a bench scientist and teacher with his deep experience in all aspects of high-stakes biotech, pharmaceutical, and medical device patent litigation.

Dr. Loeb has represented clients before U.S. District Courts, the International Trade Commission, and the Federal Circuit Court of Appeals. Dr. Loeb also represents clients in reexamination proceedings before the U.S. Patent Office and has provided advice in patent revocation and infringement actions in various foreign jurisdictions.

Before attending Stanford Law School, Dr. Loeb obtained his Ph.D. in Biology from the Massachusetts Institute of Technology. At M.I.T., Dr. Loeb worked at the Whitehead Institute for Biomedical Research with its then director, Professor Gerald R. Fink. Dr. Loeb's doctoral research concerned the genetics and cell biology of the Nuclear Pore Complex in Saccharomyces cerevisiae. After receiving his Ph.D., Dr. Loeb did post-doctoral research at M.I.T. and the University of California, Irvine, focusing on the pathogenesis of fungi that afflict immunocompromised individuals. Dr. Loeb is experienced in many biotechnologies, from molecular genetics, biochemistry, fluorescent proteins, and microscopy. Dr. Loeb is lead author of a number of scientific papers in peer-reviewed biology journals.

Dr. Loeb is routinely named a "Life Sciences Star" by LMG Life Sciences. In 2019 and 2020, Dr. Loeb was named an Outstanding Volunteer for work for the Justice & Diversity Center of the Bar Association of San Francisco (JDC). Dr. Loeb was recognized by The Legal 500 US for Patent Litigation in 2020.